NO954389L - Fosfonosulfonat-squalensyntetase-inhibitor-salter og fremgangsmåte - Google Patents

Fosfonosulfonat-squalensyntetase-inhibitor-salter og fremgangsmåte

Info

Publication number
NO954389L
NO954389L NO954389A NO954389A NO954389L NO 954389 L NO954389 L NO 954389L NO 954389 A NO954389 A NO 954389A NO 954389 A NO954389 A NO 954389A NO 954389 L NO954389 L NO 954389L
Authority
NO
Norway
Prior art keywords
salt
squalene synthetase
synthetase inhibitor
phosphonosulfonate
inhibitor salts
Prior art date
Application number
NO954389A
Other languages
English (en)
Norwegian (no)
Other versions
NO954389D0 (no
Inventor
Yadagiri Pendri
Chung Pin Chen
David J Kucera
Eduardo J Martinez
Paul D Pansegrau
John K Thottathil
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of NO954389D0 publication Critical patent/NO954389D0/no
Publication of NO954389L publication Critical patent/NO954389L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4003—Esters thereof the acid moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4056—Esters of arylalkanephosphonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/38—Phosphonic acids [RP(=O)(OH)2]; Thiophosphonic acids ; [RP(=X1)(X2H)2(X1, X2 are each independently O, S or Se)]
    • C07F9/40—Esters thereof
    • C07F9/4071—Esters thereof the ester moiety containing a substituent or a structure which is considered as characteristic
    • C07F9/4075—Esters with hydroxyalkyl compounds

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Enzymes And Modification Thereof (AREA)
NO954389A 1994-11-03 1995-11-02 Fosfonosulfonat-squalensyntetase-inhibitor-salter og fremgangsmåte NO954389L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US33366194A 1994-11-03 1994-11-03

Publications (2)

Publication Number Publication Date
NO954389D0 NO954389D0 (no) 1995-11-02
NO954389L true NO954389L (no) 1996-05-06

Family

ID=23303735

Family Applications (1)

Application Number Title Priority Date Filing Date
NO954389A NO954389L (no) 1994-11-03 1995-11-02 Fosfonosulfonat-squalensyntetase-inhibitor-salter og fremgangsmåte

Country Status (14)

Country Link
EP (1) EP0710665A1 (OSRAM)
JP (1) JPH08208672A (OSRAM)
KR (1) KR960017680A (OSRAM)
CN (1) CN1130188A (OSRAM)
AU (1) AU3458795A (OSRAM)
CA (1) CA2159850A1 (OSRAM)
CZ (1) CZ279595A3 (OSRAM)
FI (1) FI955256L (OSRAM)
HU (1) HUT73140A (OSRAM)
IL (1) IL115537A0 (OSRAM)
NO (1) NO954389L (OSRAM)
PL (1) PL311218A1 (OSRAM)
TW (1) TW318852B (OSRAM)
ZA (1) ZA959326B (OSRAM)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2780974B1 (fr) * 1998-07-08 2001-09-28 Sod Conseils Rech Applic Utilisation de derives d'imidazopyrazines pour preparer un medicament destine a traiter les pathologies qui resultent de la formation de la proteine g heterotrimetrique
WO2002038180A1 (en) * 2000-11-09 2002-05-16 Takeda Chemical Industries, Ltd. High-density lipoprotein-cholesterol level elevating agent
CA2606289C (en) 2005-04-18 2015-03-03 The Regents Of The University Of California Antimicrobial therapy for bacterial infections
KR101385868B1 (ko) * 2006-05-12 2014-04-17 유니버시티 오브 일리노이즈 앳 어바나-샴페인 세균 감염에 대한 항균 요법
CN101580472B (zh) * 2009-06-24 2013-07-10 广西壮族自治区化工研究院 1,1'-联-2-萘酚的拆分剂以及拆分方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2107644A1 (en) * 1992-10-28 1994-04-29 David R. Magnin .alpha.-phosphonosulfonae squalene synthetase inhibitors and methd
US5312814A (en) * 1992-12-09 1994-05-17 Bristol-Myers Squibb Co. α-phosphonocarboxylate squalene synthetase inhibitors

Also Published As

Publication number Publication date
JPH08208672A (ja) 1996-08-13
AU3458795A (en) 1996-05-09
NO954389D0 (no) 1995-11-02
IL115537A0 (en) 1996-01-19
PL311218A1 (en) 1996-05-13
FI955256A7 (fi) 1996-05-04
HU9503136D0 (en) 1995-12-28
ZA959326B (en) 1997-05-05
CA2159850A1 (en) 1996-05-04
FI955256A0 (fi) 1995-11-02
HUT73140A (en) 1996-06-28
CN1130188A (zh) 1996-09-04
KR960017680A (ko) 1996-06-17
TW318852B (OSRAM) 1997-11-01
EP0710665A1 (en) 1996-05-08
CZ279595A3 (en) 1996-08-14
FI955256L (fi) 1996-05-04

Similar Documents

Publication Publication Date Title
WO1996040745A3 (en) Amino acid amides of 5-amino-1,3,4-thiadiazones and their use as inhibitors for matrix metalloproteinases
GR3024133T3 (en) Isoxazoline compounds as antiinflammatory agents
MX9804623A (es) Precursores inactivos de farmacos inhibidores de trombina.
BG102738A (en) Inhibitors of farnesyl-protein transferase
DK327689A (da) Diphosphonsyrederivater, fremgangsmaade til deres fremstilling og laegemidler indeholdende disse forbindelser
DK0526488T3 (da) Benzylphosphonsyre-tyrosinkinaseinhibitorer
SG52659A1 (en) Saccharin derivative proteolytic enzyme inhibitors
BR0010220A (pt) Compostos de pirimidinona
CA2144372A1 (en) Composition for water treatment
FI971974A0 (fi) Tienopyridiini- tai tienopyrimidiinijohdannaiset ja niiden käyttö
MY112413A (en) Substituted heterocyclic carboxamides, their preparation and their use as pharmaceuticals
AU7107496A (en) Protein tyrosine kinase inhibitors for treating osteoarthritis
MY116539A (en) New amino acid derivatives
BR9916272A (pt) 4 e 5-alquiniloxindóis e 4 e 5-alqueniloxindóis
CA2020858A1 (en) Water treatment agent and water treatment method for boiler
EE9700343A (et) Meetod jääkmuda töötlemiseks
NO954389L (no) Fosfonosulfonat-squalensyntetase-inhibitor-salter og fremgangsmåte
MA23790A1 (fr) Procede pour desactiver ou detruire des microorganismes
MX9803645A (es) Microparticulas minerales sinteticas, auxiliar de retencion, sistemas de tratamiento de agua y metodos que usan dichas particulas.
AU2157500A (en) Combinations of cholesteryl ester transfer protein inhibitors and bile acid sequestering agents for cardiovascular indications
DK0712278T3 (da) N-pyridyltoluidinholdigt svampedræbende, vanddispergerbart granulat
WO2000023060A8 (en) Method of treating immunological disorders mediated by t-lymphocytes
MY112593A (en) A storage stable water solution for infusion containing a thrombin inhibitor
IL100819A0 (en) Microbiological process for the preparation of 6-hydroxypicolinic acid
AU7063287A (en) A composition for inhibiting corrosion in industrial cooling waters and a method for improving the performance of corrosion inhibitors in same